Meta Biomed Corrects Decision to Acquire Treasury Shares Worth 3 Billion Won
-
Decision to acquire treasury shares worth 3 billion won (common stock) for shareholder value enhancement and employee compensation
-
Corrected daily purchase order limit to 74,812 shares (from 74,813 shares)
-
Expected acquisition period: completion by first half of 2026, may end early
-
Acquired shares to be cancelled or used for employee performance compensation after a certain period
-
Acquisition within distributable profits
KOSDAQ Filing Information
-
Filing: [Correction of Description] Material Change Report (Decision to Acquire Treasury Shares)
-
Company: METABIOMED (059210)
-
Submission: METABIOMED.CO.,LTD
-
Receipt: 05-14-2026